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1  | INTRODUC TION
While the COVID-19 pandemic has raised many public health chal-
lenges that are universal, the task of conceiving ethical responses to 
these challenges must take historical, political and social contexts 
into account.
In this paper, we reflect on two broad ethical questions in regard 
to the COVID-19 pandemic in the sub-Saharan African (SSA) con-
text. First, how might some of the ethical recommendations offered 
so far in high-income countries appear from a resource poor SSA 
perspective? Second, what are some of the key ethical challenges 
raised by the COVID-19 pandemic in low-income countries suffering 
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Abstract
The COVID-19 pandemic has raised important universal public health challenges. 
Conceiving ethical responses to these challenges is a public health imperative but 
must take context into account. This is particularly important in sub-Saharan Africa 
(SSA). In this paper, we examine how some of the ethical recommendations offered so 
far in high-income countries might appear from a SSA perspective. We also reflect on 
some of the key ethical challenges raised by the COVID-19 pandemic in low-income 
countries suffering from chronic shortages in health care resources, and chronic high 
morbidity and mortality from non-COVID-19 causes. A parallel is drawn between the 
distribution of severity of COVID-19 disease and the classic “Fortune at the bottom 
of the pyramid” model that is relevant in SSA. Focusing allocation of resources dur-
ing COVID-19 on the ‘thick’ part of the pyramid in Low-to-Middle Income Countries 
(LMICs) could be ethically justified on utilitarian and social justice grounds, since 
it prioritizes a large number of persons who have been economically and socially 
marginalized. During the pandemic, importing allocation frameworks focused on the 
apex of the pyramid from the global north may therefore not always be appropri-
ate. In a post-COVID-19 world, we need to think strategically about how health care 
systems can be financed and structured to ensure broad access to adequate health 
care for all who need it. The root problems underlying health inequity, exposed by 
COVID-19, must be addressed, not just to prepare for the next pandemic, but to care 
for people in resource poor settings in non-pandemic times.
K E Y W O R D S
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from chronic shortages in health care resources, and chronic high 
morbidity and mortality from non-COVID-19 causes?
To respond to these questions, we take the recommendations for 
fair allocation offered by Emanuel et. al.1 in the New England Journal 
of Medicine as a sounding board and point of departure. These rec-
ommendations, authored by prominent bioethics figures in arguably 
one of the most prestigious medical journals in the world, and cited 
530 times in the space of less than four months (March 23-July 8, 
2020), have many commonalities with others currently being offered 
in North America and Western Europe. In the process, it will become 
clear that our ethical concerns in regard to COVID-19 in SSA include, 
but extend beyond, the design of fair allocation schemes for me-
chanical ventilators and intensive care units (ICUs). For the bigger 
picture, and one more relevant to resource poor settings in Low-to-
Middle Income Countries (LMICs) in Africa, our group taps into its 
own longstanding experiences as bioethics scholars working in 
South Africa, Democratic Republic of Congo (DRC), Kenya, Zambia, 
Ethiopia and Madagascar.
2  | SAVING LIVES AND SAVING YE ARS
Emanuel et. al.2 recommend that scarce medical resources be allo-
cated in ways that maximize benefits, and more specifically, that 
maximize the number of lives saved and improvements in patients’ 
years of post-treatment life. They argue that this recommendation 
enjoys considerable agreement among experts and can be ethically 
defended on both utilitarian (i.e. best overall outcomes) and non-
utilitarian (i.e. value of human life) grounds. In practice, this will mean 
prioritizing the allocation of scarce resources to patients who are 
likely to recover and will have a reasonable life expectancy. On this 
basis, their approach generally favors younger patients over older 
ones, which Emanuel et al.3 further justify with a life-cycle argu-
ment: each person should have an equal opportunity to live through 
the various phases of life.
The recommendation may be intuitively appealing, but it also 
may be difficult to apply or lead to counterintuitive conclusions. For 
example, say we are comparing a 34-year-old male with very few 
skills and a history of smoking and substance use with a highly skilled 
50-year-old woman with a history of asthma, who is supporting her 
children and parents. Both patients are diagnosed with COVID-19 
with similar likelihood of recovery. In the Emanuel et al.4 scheme, and 
others like it, we are asked to strip away all patient characteristics 
deemed morally irrelevant. There are ethical reasons to disagree 
with this move. When a pandemic strikes impoverished communities 
that were only just getting by pre-COVID-19, there are 
understandable consequentialist reasons to favor individuals who 
are crucial to their family or community network. Although bringing 
in considerations of a person’s ‘social worth’ in allocation schemes is 
controversial, and can be difficult (and sometimes impossible) to im-
plement in fast-moving triage decisions, leaving them out of all such 
decision-making can also be problematic. Where Clinical Ethics 
Committees (CECs) or triage committees on the frontline are ex-
pected to assist with choosing between two patients with equivalent 
clinical conditions and prognosis for one ICU bed, social justice con-
siderations may become the only tie-breaker.
In addition, the life-cycle argument, promoted as a tie-breaker in 
situations where prognoses are similar, is assumed to be universal. This 
is not obvious. Is it universally accepted that, when forced to choose, a 
young person’s life should always take precedence (other relevant con-
siderations being equal) over that of someone older? Or does the 
life-cycle argument reflect the values and life-course conceptions of 
particular cultures?5 For example, Jecker argues that in some LMIC set-
tings the aged are regarded other than persons whose worth is dimin-
ished by ‘already having had their fair share’ of living.6 The few studies 
of this question have been limited to high-income countries.7 There are 
ethical reasons to take local community views about the life-course 
into consideration when making decisions about resource allocation. If 
the ‘fair innings’ conception of the life course is alien to how communi-
ties associate age and value, then using ‘fair innings’ as a tiebreaker 
may be regarded as an imposition of an alien construct and undermine 
community trust in the basis on which life and death decisions are 
being made. More empirical research and community engagement are 
needed before assuming that life-cycle arguments embedded in influ-
ential resource allocation schemes (mostly from North America) reflect 
the values of communities worldwide.
3  | HE ALTH C ARE WORKERS: PRIORIT Y 
ACCESS AND DECISION-MAKING
In SSA, health care professionals are a highly valued resource, particu-
larly during a pandemic. While they themselves are relatively scarce, 
unlike ventilators or other equipment, they “cannot be urgently manu-
factured or run at 100% capacity or occupancy for long periods”.8
During the COVID-19 crisis, many have been working on the front-
lines with suboptimal personal protective equipment (PPE) and poor 
access to testing. All frontline workers, including supportive staff, are 
 1Emanuel, E.J., Persad, G., Upshur, R., et al. (2020). Fair Allocation of Scarce Medical 





 5Schweda, M., Pfaller, L., Brauer, K., Adloff, F., & Schicktanz, S. (2017). “A season to 
everything”? Considering life-course perspectives in bioethical and public-health 
discussions on ageing. Planning Later Life: Bioethics and Public Health in Aging Societies 
(Eds.). London: Routledge.
 6Jecker, N.S. (2020). African Conceptions of Age-Based Moral Standing: Anchoring 
Values to Regional Realities. Hastings Center Report. 50(2), 35–43. https://doi.
org/10.1002/hast.1100.
 7Biddison, E.L.D., Gwon, H.S., Schoch-Spana, M., et al. (2018). Scarce Resource 
Allocation During Disasters: A Mixed-Method Community Engagement Study. Chest. 
153(1), 187–195. https://doi.org/10.1016/j.chest.2017.08.001.
 8Ntusi, N. (2019). South African Heart Journal 2019 : A year in review. S Afr Med J. (4), 
2–5.
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taking risks and deserve priority on reciprocity and utility grounds. But 
in resource poor settings, scarcity is likely to dictate that priority access 
to scarce health care resources only be extended to healthcare profes-
sionals directly involved in COVID-19 patient care who become sick. 
In these circumstances, having any sort of ‘priority lane’ to health care 
is controversial, and therefore broad policies about which health care 
workers should be given priority and why (i.e. their role in pandemic 
response) should ideally be a matter of public debate.
In regard to the process of making patient care allocation decisions, 
Emanuel et al.9 suggest taking the burden largely out of the hands of 
clinicians, or even individual health institutions. They advocate for an 
approach where others (such as triage officers or committees of physi-
cans and ethicists) formulate standardized guidance, and help physi-
cians make decisions. This, they argue, will help minimize the burden of 
emotional distress on clinicians and the subjectivity of ‘a clinician’s intu-
ition in the heat of the moment.’ But it is not clear that such a division of 
labor between clinicians and triage committees is necessary or feasible. 
In resource poor settings in LMICs, triage decisions are made all the 
time, for all kinds of conditions, in accordance with well-thought out 
triage policies by experienced and highly skilled critical care doctors, 
nephrologists, emergency medicine doctors and primary care physi-
cians. This is in response to chronic shortages of many health interven-
tions including simple measures like antibiotics, antiretroviral drugs and 
even analgesics in addition to dialysis and ventilation. While the swift-
ness, magnitude and uncertainties of the COVID-19 pandemic differ 
from situations of medical scarcity experienced in the past, how this is 
expressed in clinical situations will not be completely unprecedented. 
Furthermore, in the heat of the moment, who is to say that ‘clinical in-
tuition’ is necessarily worse than decision-making based on sophisti-
cated allocation schemes overseen by a triage committee? It partly 
depends on what is meant here by ‘intuition’. If intuition means impul-
sive, subjective and idiosyncratic judgments by doctors, it clearly 
should not play any role. On the other hand, if it means the experienced 
perception of those who have long engaged with the implementing of 
triage criteria in particular cases across a variety of contexts, and whose 
judgments have been regarded as reasonable over a history of cases, it 
would be prudent not to sideline this kind of expertise in the process of 
allocation decision-making, even if it is obviously not infallible.10 It is 
even less prudent to do so in resource poor settings in LMICs where it 
may be challenging to establish effective allocation committees with 
independent intensivists and bioethicists. This issue about deci-
sion-making processes is not just an issue in LMICs: in some New York 
hospitals, practical and legal considerations made the use of Sequential 
Organ Failure Assessment (SOFA) scores and Triage Committees un-
feasible (webinar presentation – Dr Katherine Fischkoff, New York 
Presbyterian Hospital).11 When these triage decisions needed to be 
made in hospital emergency rooms during the surge in New York City, 
use of SOFA scores was simply not possible (webinar presentation, Dr 
Nancy Dubler,12 New York City Health and Hospitals Corporation). 
More empirical work is needed on how triage decisions are actually 
made (and can be made) in pandemic circumstances, in LMICs and else-
where, before recommending the marginalization of judgments by ex-
perienced clinicians.
4  | LOT TERY-BA SED ALLOC ATION
Emanuel et al.13 argue that when patients have similar prognoses, 
the best way of allocating scarce medical resources fairly is through 
random allocation, such as a lottery. This could arise, for example, 
when two or more patients have equal chances of recovery and the 
life-years saved would be roughly the same. Random allocation, they 
argue, is superior as a tie-breaker to a first-come, first-served ap-
proach, because the latter may unfairly favor those living closer to 
medical facilities, lead to crowding and increased transmission risk, 
and disadvantage those who need health care later because they 
were adherent to public health guidelines.
While lottery-based allocations of scarce medical resources are 
sometimes promoted in bioethics theories, they are rarely used in prac-
tice.14 Part of the reason may be that lotteries are difficult to govern 
and susceptible to corruption whenever there is a great deal at stake. In 
countries like the DRC, for example, highly valued scarce resources are 
most likely to be allocated to powerful members of Congolese soci-
ety.15 In many LMICs, communities may have good reasons to doubt 
whether medical resource lotteries would be truly random.
In addition, even if a lottery-based approach was well-gov-
erned, the allocation of lifesaving resources in some communities 
may appear to trivialize human life rather than embodying ideal 
rationality and impartiality. In the interests of transparency and 
accountability, the presence of a lottery element in allocations 
would need to be publicized and negotiated with affected commu-
nities. There is no guarantee that such an approach would be 
found acceptable, though attitudes may differ towards lotteries 
for allocating preventive interventions (such as vaccines) as op-
posed to treatments.16
 9Emanuel, Persad, Upshur, Thome, Parker, Glickman, et al. (op. cit. n. 1) : 1–7.
 10Christen, M., Van Schaik, C., Fischer, J., Huppenbauer, M., Tanner, C. (2015). Empirically 
Informed Ethics: Morality between Facts and Norms by Christen et al. Filosofia Unisinos 
(Vol. 16). https://doi.org/10.4013/fsu.2015.162.07
 11Fischkoff, K. (2020). COVID-19: Ethical Dilemmas in Human Lives (ZOOM). Retrieved 
from https://globa lcent ers.colum bia.edu/event s/covid -19-ethic al-dilem mas-human -lives 
-zoom.
 12Dubler, N.N. (2020). COVID-19: Ethical Issues in the Management of COVID-19. 
Retrieved June 25, 2020, from https://www.netwo rkfor phl.org/resou rces/covid 
-19-ethic al-issue s-in-the-manag ement -of-covid -19/.
 13Emanuel, Persad, Upshur, Thome, Parker, Glickman, et al. (op. cit. n. 1) : 1–7.
 14Scheunemann, L.P., & White, D.B. (2011). The ethics and reality of rationing in 
medicine. Chest. 140(6), 1625–1632. https://doi.org/10.1378/chest.11-0622.
 15Dizolele, M.P. (2010). The mirage of Democracy in the DRC. Journal of Democracy. 
21(3), 143–157. https://doi.org/10.1353/jod.0.0189.
 16McLachlan, H. V. (2012). A proposed non-consequentialist policy for the ethical 
distribution of scarce vaccination in the face of an influenza pandemic. Journal of Medical 
Ethics. 38(5), 317–318. https://doi.org/10.1136/medet hics-2011-100031; Wardrope, A. 
(2012). Scarce vaccine supplies in an influenza pandemic should not be distributed 
randomly: Reply to McLachlan. Journal of Medical Ethics. 38(12), 765–767. https://doi.
org/10.1136/medet hics-2012-100750; Zimmerman, R.K. (2007). Rationing of influenza 
vaccine during a pandemic: Ethical analyses. Vaccine. 25(11), 2019–2026. https://doi.
org/10.1016/j.vacci ne.2006.11.045.
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5  | RESE ARCH PARTICIPATION AND 
RESOURCE ALLOC ATION
Emanuel et al.17 argue that participation in COVID-19 related re-
search should function as a tie-breaker in cases where patients have 
similar prognoses. As a matter of desert, priority access to scarce 
medical resources should be given to those who help future patients 
by volunteering for research, and who expose themselves to study-
related risks. This reward, they argue, will also encourage other pa-
tients to join such trials.
It is reasonable to claim that it is ethically imperative to conduct 
research during pandemics, particularly ones where (as in the case of 
COVID-19) there is no effective vaccine or treatment. Such studies 
need volunteers in sufficient numbers in order to be scientifically 
valid. This being said, making research participation a deciding factor 
in allocation decisions remains problematic. Setting up such a system 
will undoubtedly encounter practical challenges, such as how to 
track those who have participated in research over time and how to 
conduct research activities without unduly disrupting patient care. 
But the main ethical problem has to do with voluntary consent. In 
pandemic circumstances, marked by limited access to medical (in-
cluding lifesaving) resources, are those who join research studies in 
order to gain a (potentially lifesaving) medical benefit making a vol-
untary choice? Or is this a case of ‘structural coercion’?18 This is es-
pecially relevant to low resource settings in LMICs, where concerns 
about exploitation often arise when individuals are offered medical 
benefits that are otherwise unobtainable for them by joining bio-
medical research studies. In LMICs during the COVID-19 pandemic, 
it is likely that the conditions for valid informed voluntary consent 
will be seriously undermined. The question is less whether and how 
to reward research participation within an allocation scheme and 
more how to conduct research ethically in pandemic circumstances 
of fear, grief, social disruption, poverty and entrenched injustice.
6  | COVID -19 PATIENTS AND PATIENTS 
WITH OTHER CONDITIONS
Emanuel et al.19 rightly point out that some of the medical resources 
needed by COVID-19 patients will also be needed by patients with 
cancer, heart failure or non-COVID-19 related respiratory diseases. 
They argue that there should be no difference in allocating scarce 
resources between patients with COVID-19 and those with other 
medical conditions. Similarly, White and Lo (2009)20 state that in or-
dinary clinical practice, patients who require life sustaining treat-
ments should receive them, except if they or their surrogates refuse, 
or in the rare circumstances in which they are deemed medically fu-
tile. This issue is especially relevant to LMICs.
Is equity in access between COVID-19 and non-COVID-19 pa-
tients a reasonable ideal in the context of LMICs? There are two is-
sues here: is the recommendation ethically desirable, and can the 
recommendation actually be followed?
The ethical recommendation of equitable access is intuitively de-
sirable. In practical terms, it entails treating non-COVID-19 patients 
needing emergency care the same as if the COVID-19 pandemic 
had not happened. This would require retaining original ICU beds, 
high flow oxygen and ventilators for non-COVID-19 patients and 
setting up additional equivalent resources for COVID-19 patients. 
Ideally, scarce ICU beds or other relevant resources are not allo-
cated specifically or prioritised for COVID-19 patients; one simply 
looks at patient need and potential for benefit for COVID-19 and 
non-COVID-19 patients alike. The question is to what extent this at-
tractive recommendation can help guide health system responses in 
resource poor settings in LMICs faced with a rapid spike in COVID-
19 cases together with a longstanding, pre-existing inability of those 
systems to provide sufficient critical care for non-COVID patients 
who need it.
The attainability of the equity ideal seems highly remote in many 
resource poor LMIC clinics and hospitals, who are unable to provide 
what White and Lo call ‘ordinary clinical practice’. Prior to the 
COVID-19 pandemic, many critically ill patients in low resource set-
tings in LMICs were not able to access the medical resources they 
needed. A systematic review by Murthy et al. (2015)21 revealed that 
ICU capacity in low-income countries is extremely weak; for exam-
ple, Uganda only had one ICU bed per million population.22 Kinshasa, 
the capital of the DRC, has roughly 100 ventilators for an estimated 
15 million people, some of which are in private hospitals and nor-
mally reserved for surgical cases (personal communication). In such 
settings, distributing critical care resources equally between COVID-
19 and non-COVID-19 patients would be challenging, if not impossi-
ble. Early in the pandemic, South Africa had 7195 ICU beds of which 
4917 were in the private sector.23 Although these statistics are 
changing modestly as donations of ventilators have increased in the 
past few weeks, supply remains suboptimal in the face of growing 
demand. While some hospitals have separate COVID-19 and non-
COVID-19 ICUs, others do not. In the interests of equity, is it justifi-
able to keep non-COVID-19 ICU beds empty, when there is a surge 
of COVID-19 patients requiring critical care? And, given that COVID-
19 patients may occupy ICU beds or ventilators for longer than 
 17Emanuel, Persad, Upshur, Thome, Parker, Glickman, et al. (op. cit. n. 1) : 1–7.
 18Fisher, J.A. (2013). Expanding the frame of ‘Voluntariness’ in informed consent: 
Structural coercion and the power of social and economic context. Kennedy Institute of 
Ethics Journal. 23(4), 355–379. https://doi.org/10.1353/ken.2013.0018.
 19Emanuel, Persad, Upshur, Thome, Parker, Glickman, et al. (op. cit. n. 1) : 1–7.
 20White, D.B., Katz, M.H., Luce, J.M., & Lo, B. (2009). Who should receive life support 
during a public health emergency? Using ethical principles to improve allocation 
decisions. Annals of Internal Medicine. 150(2), 132–138. https://doi.org/10.7326/0003-
4819-150-2-20090 1200-00011.
 21Murthy, S., Leligdowicz, A., & Adhikari, N.K.J. (2015). Intensive care unit capacity in 
low-income countries: A systematic review. PLoS ONE. 10(1), 1–12. https://doi.
org/10.1371/journ al.pone.0116949.
 22Ibid.
 23van den Heever, A. (2020). Projections on SA health system and whether there are 
enough hospital beds to cope. Retrieved May 20, 2020, from https://www.daily maver 
ick.co.za/artic le/2020-03-16-proje ction s-on-sa-healt h-syste m-and-wheth er-there 
-enoug h-hospi tal-beds-to-cope/.
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non-COVID-19 patients, how does equity play out under such 
circumstances?
The anticipated rise of COVID-19 infections is likely to aggravate 
scarcity of critical care resources in resource poor settings in LMICs 
significantly. Some patients who might have gained access to criti-
cal care a few months ago could be tragically out of luck during the 
COVID-19 crisis. Equity requires the presence of resources many of 
these clinics and hospitals have not had and do not have.
7  | COVID -19 IN LMICs IN SUB-SAHAR AN 
AFRIC A: WIDENING THE ETHIC AL LENS
In the context of resource poor settings in LMICs, the allocation 
issue presented by Emanuel et. al.24 would affect a vanishingly small 
number of people: the relatively few in need who had the ability to 
access and benefit from what few critical care resources are availa-
ble. It is not clear that this is a burning issue even in high-income 
countries, as only a much smaller proportion of COVID-19 patients 
than previously anticipated stand to benefit from mechanical venti-
lation and other critical care interventions.25 This development un-
dermines the idea that the main ethical question about allocation of 
scarce medical resources during the COVID-19 crisis is about how to 
distribute mechanical ventilators and ICU beds. But even before the 
limitations of mechanical ventilation for COVID-19 care were recog-
nized, this ethical debate was of little relevance to many sub-Saharan 
African countries where ICUs and ventilators may be extremely 
scarce or even non-existent.26 So what are some of the key ethical 
issues in regard to COVID-19 faced by resource poor settings in 
LMICs in sub-Saharan Africa?
The context of LMICs is different, and a change of paradigm is 
required. Baker et al. describe the distribution of the COVID-19 se-
verity in terms of a pyramid, with a small minority (5%) of the most 
severely ill patients located at the apex and the vast majority (80%) 
spread out over the middle and the base.27 Most patients have mild 
(40%) or moderately severe disease (40%) that is likely responsive to 
less complex treatments like oxygen and other forms of supportive 
therapy.28
The pyramid metaphor is instructive, as it suggests a way of 
framing ethical responses to the COVID-19 crisis in LMICs more gen-
erally. Prahalad and Hart famously created a socio-economic 
pyramid with four tiers of global wealth, with an affluent minority at 
the apex, and the remaining vast majority having diminished wealth 
to a greater or lesser degree.29 The socio-economic inequities within 
countries between the apex and the rest is measured in terms of the 
GINI coefficient. Six out of ten countries with the highest GINI co-
effients are in sub-Saharan Africa, and South Africa has the highest 
GINI coefficient in the world.30 Those not belonging to the apex of 
the pyramid in these countries – again, the vast majority of persons 
- not only have less wealth, but have much worse health indicators 
and greatly reduced access to quality health care. Focusing alloca-
tion of resources during COVID-19 on the ‘thick’ part of the pyramid 
in LMICs could be ethically justified on utilitarian and social justice 
grounds, since it prioritizes a large number of persons who have 
been economically and socially marginalized.
To take the pyramid metaphor further, the needs of those at the 
bottom of the pyramid are also best met through different distribu-
tion channels of healthcare – mobile clinics and field workers going 
out to communities as compared to health systems that require peo-
ple to present to tertiary hospitals and critical care units. The South 
African response to COVID-19, has included a combination of mass 
screening and targeted testing implemented by an army of 28 000 
health workers who have been trained to work in communities as 
part of the strategy implemented in the fight against HIV and 
Tuberculosis.31
Yet another concept emphasized by Prahalad and Hart is the im-
portance of combining local and global knowledge instead of repli-
cating approaches from the global north that may not be 
implementable in the global south such as LMICs in SSA. The adviso-
ries around social distancing or physical distancing included in all 
WHO guidance has been met with sharp criticism in many African 
and other LMIC settings where overcrowding in informal settle-
ments makes any form of distancing challenging.32 This challenge in 
physical distancing also exists in High Income Countries (HICs) such 
as the United States where, due to similar health inequities, a dispro-
portionate burden of disease has been borne by poor “bottom of the 
pyramid” communities in high density neighbourhoods with so-
cio-economic disadvantage.33
 24Emanuel, Persad, Upshur, Thome, Parker, Glickman, et al. (op. cit. n. 1) : 1–7.
 25Gattinoni, L., Marini, J.J., Collino, F., et al. (2017). The future of mechanical ventilation: 
Lessons from the present and the past. Critical Care. 21(1), 1–11. https://doi.org/10.1186/
s1305 4-017-1750-x.
 26R. Maclean, S.M. (2020). 10 “African countries have no ventilators. That’s only part of 
the program,” New York Times. April 18, 2020. https://www.nytim es.com/2020/04/18/
world/ afric a/afric a-coron aviru s-venti lators.html. Retrieved May 2, 2020, from https://
www.nytim es.com/2020/04/18/world/ afric a/afric a-coron aviru s-venti lators.html.
 27Baker, T., Schell, C.O., Petersen, D.B., et al. (2020). Essential care of critical illness must 
not be forgotten in the COVID-19 pandemic. The Lancet. 395(10232), 1253–1254. 
https://doi.org/10.1016/S0140 -6736(20)30793 -5.
 28Halpern, S.D., & Miller, F.G. (2020). The Urge to Build More Intensive Care Unit Beds 
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It is becoming evident that in seeking solutions to ending the 
pandemic, in LMICs, we should be seeking approaches that combine 
utilitarian and justice considerations, i.e. those that assist the great-
est number who have historically been most at the (negative) receiv-
ing end of the social determinants of health. The COVID-19 crisis is 
bringing into mainstream consciousness what infectious disease ep-
idemiologists (often working in LMICs) have known for decades: that 
health inequities rooted in unjust social structures dramatically 
worsen the impact of epidemics on society as a whole.34 Issues 
about allocation of scarce medical resources (in LMICs and else-
where) cannot be meaningfully discussed independently of public 
health responses.35 The more effectively SARS-CoV-2 transmissions 
are reduced by public health measures and community action, the 
less demand there will be for medical resources. However, mounting 
an effective public health response against COVID-19 in LMICs 
faces considerable challenges, and it is not clear that approaches fa-
vored in privileged communitites in HICs can be cut-and-pasted into 
resource poor settings in LMICs.36 Even seemingly simple measures 
such as regular hand washing and use of hand sanitizer come at a 
non-negligible cost in such settings in LMICs. In the Democratic 
Republic of Congo, 73% of the population live on less than 2 US dol-
lars per day.37 In Kinshasa, liquid soap (30cl) costs between 1 and 1.5 
US dollars. The size of the average household in Kinshasa is 7 per-
sons. This means that to follow the recommendation, 4-7 dollars per 
week would need to be spent by each household. In addition, the 
majority of the population do not have piped water in their houses, 
setting up a conflict between recommendations to wash hands and 
to keep social distance. These measures are more feasible for those 
higher up in the pyramid.
In addition, the ethics of a national lockdown in LMICs should 
be examined in the light of local realities. Privileged groups 
within LMICs are likely to be relatively insulated from the im-
pacts of severe public health restrictions. This is not true for the 
rest of the population. The vast majority of economic activities 
(including the ‘informal economy’) cannot be conducted online 
and unlike high income countries, there is little hope of govern-
ments providing sufficient financial compensation for workers 
or businesses. In LMICs, the use of measures like closing all but 
non-essential services for an extended period of time could 
drive some populations even further into poverty or even pro-
voke a famine.38 The requirement to ‘remain in place’ in LMICs is 
also likely to result in even greater social isolation than in privi-
leged communities in middle and high-income countries, where 
most individuals and families can continue to stay in touch via 
electronic devices and reliable internet service. Public health 
approaches may need to be applied selectively, i.e. depending on 
the burdens they place on different socio-economic groups. 
Without such nuance, strategies which may be more workable 
elsewhere may require sacrifices in resource poor settings in 
LMICs so profound that they could undermine trust in govern-
ment and threaten to bring the credibility of global public health 
agencies into question.
Scarcity of resources mirrors the Prahalad and Hart pyramid 
more closely than we may think. The scarcity at the bottom of 
the pyramid in the face of a disproportionate demand is exacer-
bated by global geopolitical forces that place Africa last in line in 
procurement of medical supplies, even where countries may 
have the financial means to ramp up resources. Testing kits, PPE 
and medication, are being preferentially supplied to countries 
with asymmetric purchasing power.39 This may apply to future 
vaccines as well.40
8  | CONCLUSIONS
The Emanuel et al.41 article, and others like it, are focused on deci-
sion-making for allocations of scarce critical care resources in re-
sponse to COVID-19. Although not explicitly intended for export 
to resource poor settings in LMICs, such recommendations by 
leading figures in bioethics, published by prestigious medical jour-
nals, often influence policy-makers worldwide. The recommenda-
tions typically do not come with a disclaimer that they might not 
apply or may need to be reinterpreted when used elsewhere. This 
is a characteristic they share with many public health recommen-
dations during COVID-19, promoted by powerful global health 
agencies. But how to fairly allocate scarce medical resources and 
how to responsibly control a novel infectious disease are ques-
tions that have to be negotiated in specific epidemiological, social 
and political contexts.
A leading ethical concern for resource poor settings in LMICs 
is how to respond to the COVID-19 pandemic, in clinical and public 
 34Abrams, E.M., & Szefler, S.J. (2020). COVID-19 and the impact of social determinants of 
health. The Lancet. Respiratory Medicine. 2019(20), 2019–2020. https://doi.org/10.1016/
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Association. https://doi.org/10.1001/jama.2020.6547; Wadhera, R.K., Wadhera, P., Gaba, 
P., et al. (2020). Variation in COVID-19 Hospitalizations and Deaths Across New York City 
Boroughs. JAMA - Journal of the American Medical Association. April, 29–31. Retrieved July 
7, 2020 from: https://jaman etwor k-com.ezpro xy.cul.colum bia.edu/journ als/jama/fulla rticl 
e/2765524; Williams, D.R., & Cooper, L.A. (2020). COVID-19 and Health Equity-A New 
Kind of ‘Herd Immunity’. Jama. https://doi.org/10.1001/jama.2020.8051; Yancy, C.W. 
(2020). COVID-19 and African Americans. JAMA - Journal of the American Medical 
Association. 60611, 5–6. https://doi.org/10.1001/jama.2020.6548.
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The New York Times.
 36Cash & Patel, op. cit. note 24: 19–20.
 37The World Bank Data, op. cit. note 22. Retrieved May 20, 2020 from: https://data.
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 38van den Heever, A., Francis, D., Venter, F., et al. (2020). South Africa needs a 
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own-strat egy-that-emula tes-south -korea.html.
 39Kavanagh, M.M., Erondu, N.A., Tomori, O., et al. (2020). Access to lifesaving medical 
resources for African countries: COVID-19 testing and response, ethics, and politics. 
Lancet (London, England). 6736(20), 19–22. https://doi.org/10.1016/S0140 
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health contexts, such as to avoid worsening existing health and 
other inequalities. Beyond avoiding the promotion of policies and 
approaches that clearly favor already privileged groups, bioethi-
cists working in LMICs are faced with many unknowns. It is pos-
sible that the overall impact of COVID-19 in Africa is relatively 
modest due to the fact that African populations are younger and 
there are very few care homes for the aged, which have been 
hotspots for infection in higher-income countries. In this opti-
mistic hypothetical scenario, demand for critical care resources 
would be low and the need for radical disease control measures 
like national lockdowns would be obviated. But it is also possible 
that some crowded areas will be hotspots for infection among 
the elderly, and prolonged exposure to the virus could increase 
severity of disease and mortality in the younger age groups. The 
epidemiological details matter for determining ethical approaches 
to saving the most lives and improving the life prospects of those 
who recover.
Despite this uncertainty, it is likely that lower-tech and easier 
to implement clinical interventions will have the greatest benefits 
for the ‘thick’ parts of the pyramid in LMICs. As with other serious 
disease threats faced by SSA in the past, this will be a commu-
nity-engaged approach mobilizing available local resources and 
expertise. Some approaches – like relying on diagnoses by clinical 
officers or paramedicals (as occurs in Malawi), rather than doctors 
conducting tests to confirm cases – may appear ‘suboptimal’ from 
some perspectives but nevertheless can reach and benefit a wide 
number of patients who might have been neglected otherwise. 
However, regardless of approach, decisions will involve painful 
costs. The COVID-19 pandemic – and what it is bringing to light - 
should invite reflection about how we got here and where we are 
going. In a post-COVID-19 world, we need to think strategically 
about how health care systems can be financed and structured 
such that there is broad access to adequate health care for all who 
need it. The root problems underlying health inequity, exposed by 
COVID-19, must be addressed, not just to prepare for the next 
pandemic, but to care for people in non-pandemic times. Most 
importantly, much work lies ahead to restore public trust in medi-
cal and public health institutions after the shortcomings of health 
care systems have been so brutally exposed in high, middle and 
low income settings alike.
9  | DEDIC ATION
This article is dedicated to the memory of Prof. Patrick Kayembe, 
who passed away during its development. Patrick was a leader in 
public health research and practice in Central Africa and beyond for 
decades, and was part of the Democratic Republic of Congo govern-
mental COVID-19 response team. He was also a passionate advocate 
for research ethics and public health ethics.
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